Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-11-25 | Wendy Johnson 0 shares owned. |
| 2015-07-10 | Wendy Johnson was appointed Interim Chief Operating Officer in September 2014 and joined our Board of Directors in May 2014. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-27 | Ms. Johnson received an M.B.A. from Loyola University Maryland, her M.S. in Clinical Microbiology from the Hahnemann Medical School (Drexel University), and her B.S. in Microbiology from the University of Maryland. Ms. Johnson’s significant experience in pharmaceutical drug development and business development, as well as her strong background in microbiology contributed to our Board's conclusion that she should serve as a director of our company. |
| 2022-04-28 | Ms. Johnson received an M.B.A. from Loyola University Maryland, her M.S. in Clinical Microbiology from the Hahnemann Medical School (Drexel University), and her B.S. in Microbiology from the University of Maryland. Ms. Johnson’s significant experience in pharmaceutical drug development and business development, as well as her strong background in microbiology contributed to our Board's conclusion that she should serve as a director of our company. |
| 2023-04-28 | Ms. Johnson received an M.B.A. from Loyola University Maryland, an M.S. in Clinical Microbiology from the Hahnemann Medical School (Drexel University), and a B.S. in Microbiology from the University of Maryland. Ms. Johnson’s significant experience in pharmaceutical drug development and business development, as well as her strong background in microbiology contributed to our Board's conclusion that she should serve as a director of our company. |
Data sourced from SEC filings. Last updated: 2026-02-03